-
Newer more sensitive troponin assays have the potential to identify acute myocardial infarction (AMI) earlier, but some detect troponin in 50% of normal populations, which renders them clinically useless.
-
The prevalence of obesity is increasing throughout the western world at an alarming rate. Obesity has been associated with higher rates of cardiovascular events, although the converse association (between weight loss and reduction in cardiovascular events) has been harder to prove.
-
In this paper, Priori and colleagues from a consortium of 10 Italian arrhythmia centers enrolled Brugada syndrome patients to evaluate the role of programmed electrical stimulation in risk stratification and to look for other novel predictors of outcome in Brugada syndrome patients.
-
This pan-European multicultural study investigates whether after initial weight loss in overweight subjects, a subsequent diet of high or low carbohydrate (glycemic index) or protein diets helped subjects maintain their new weight better.
-
-
Dronedarone was approved by the FDA in the United States for the treatment of patients with atrial fibrillation (AF) several years ago.
-
Recent clinical trials utilizing intravascular ultrasound (IVUS) to quantify coronary artery plaque burden have demonstrated that statin therapy has the potential to arrest the progression of coronary artery disease, and even to effect a small amount of plaque regression.
-
Celivarone is a noniodinated analog of amiodarone that is currently in clinical trials. This report gives us data about the effect of celivarone on ventricular arrhythmias in patients with implantable cardioverter-defibrillators (ICDs).
-
-
New indication for rivaroxaban; new study on warfarin testing; medications causing adverse drug events; niacin as an add-on therapy; and FDA actions.
